For: | Hussain HA, Harvey AJ. Evolution of breast cancer therapeutics: Breast tumour kinase’s role in breast cancer and hope for breast tumour kinase targeted therapy. World J Clin Oncol 2014; 5(3): 299-310 [PMID: 25114846 DOI: 10.5306/wjco.v5.i3.299] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v5/i3/299.htm |
Number | Citing Articles |
1 |
Dan‐dan Yu, Ying Wu, Hong‐yu Shen, Meng‐meng Lv, Wei‐xian Chen, Xiao‐hui Zhang, Shan‐liang Zhong, Jin‐hai Tang, Jian‐hua Zhao. Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Science 2015; 106(8): 959 doi: 10.1111/cas.12715
|
2 |
|
3 |
Di Wu, Bing Han, Liang Guo, Zhimin Fan. Molecular mechanisms associated with breast cancer based on integrated gene expression profiling by bioinformatics analysis. Journal of Obstetrics and Gynaecology 2016; 36(5): 615 doi: 10.3109/01443615.2015.1127902
|
4 |
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh. Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers 2023; 15(4): 1320 doi: 10.3390/cancers15041320
|
5 |
|
6 |
Yoshiaki Mizuguchi, Susan Specht, Kumiko Isse, Eizaburo Sasatomi, John G. Lunz, Toshihiro Takizawa, Anthony J. Demetris. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia. Journal of Hepatology 2015; 63(2): 399 doi: 10.1016/j.jhep.2015.02.047
|
7 |
|
8 |
Roja Sahu, Shakti P. Pattanayak. Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets. Current Gene Therapy 2020; 20(4): 237 doi: 10.2174/1566523220999200731002408
|